PURPOSE: The aim of the present study was to investigate whether pentoxifylline (PTX) treatment could protect against induced acute radiation enteritis. METHOD: Rats received 100 mg/kg/day PTX for 7 days before irradiation and continued on treatment for 3 days after irradiation. The intestinal myeloperoxidase (MPO) activities and malondialdehyde (MDA), glutathione (GSH), prostaglandin E2, and thromboxane B2 levels were determined. Terminal ileum tissue was evaluated for morphological changes. Also, nuclear factor kappa (NF-kappa), tumor necrosis factor-alpha (TNF-alpha), and intercellular adhesion molecule 1 (ICAM-1) expressions were analyzed with immunohistochemisty methods. RESULTS: PTX treatment was associated with increased GSH levels and decreased MPO activity and MDA, prostaglandin E2, and thromboxane B2 levels. Histopathologic examination showed that intestinal mucosal structure was preserved in the PTX-treated group while having significant decreases in NF-kappaB, TNF-a, and ICAM-1 expression. CONCLUSIONS: PTX appears to have a protective effect against radiation damage. This protective effect is mediated in part by decreasing both inflammatory reactions and oxidative stress.
PURPOSE: The aim of the present study was to investigate whether pentoxifylline (PTX) treatment could protect against induced acute radiation enteritis. METHOD:Rats received 100 mg/kg/day PTX for 7 days before irradiation and continued on treatment for 3 days after irradiation. The intestinal myeloperoxidase (MPO) activities and malondialdehyde (MDA), glutathione (GSH), prostaglandin E2, and thromboxane B2 levels were determined. Terminal ileum tissue was evaluated for morphological changes. Also, nuclear factor kappa (NF-kappa), tumor necrosis factor-alpha (TNF-alpha), and intercellular adhesion molecule 1 (ICAM-1) expressions were analyzed with immunohistochemisty methods. RESULTS:PTX treatment was associated with increased GSH levels and decreased MPO activity and MDA, prostaglandin E2, and thromboxane B2 levels. Histopathologic examination showed that intestinal mucosal structure was preserved in the PTX-treated group while having significant decreases in NF-kappaB, TNF-a, and ICAM-1 expression. CONCLUSIONS:PTX appears to have a protective effect against radiation damage. This protective effect is mediated in part by decreasing both inflammatory reactions and oxidative stress.
Authors: Claudia E Rübe; Falk Wilfert; Daniela Uthe; Kurt W Schmid; Reinhild Knoop; Norman Willich; Andreas Schuck; Christian Rübe Journal: Radiother Oncol Date: 2002-08 Impact factor: 6.280
Authors: Lone Gothard; Paul Cornes; Judith Earl; Emma Hall; Julie MacLaren; Peter Mortimer; John Peacock; Clare Peckitt; Mary Woods; John Yarnold Journal: Radiother Oncol Date: 2004-11 Impact factor: 6.280
Authors: J Massart; M A Robin; F Noury; A Fautrel; P Lettéron; A Bado; P A Eliat; B Fromenty Journal: Br J Pharmacol Date: 2012-03 Impact factor: 8.739
Authors: Abigail L Stockham; Manmeet Ahluwalia; Chandana A Reddy; John H Suh; Aryavarta Kumar; Michael A Vogelbaum; Gene H Barnett; Erin S Murphy; Samuel T Chao Journal: J Neurooncol Date: 2013-09-18 Impact factor: 4.130
Authors: Vasanthi R Sunil; Kinal N Vayas; Jessica A Cervelli; Rama Malaviya; LeRoy Hall; Christopher B Massa; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin Journal: Exp Mol Pathol Date: 2014-06-02 Impact factor: 3.362